tiprankstipranks
Advertisement
Advertisement
Allen Lutz Reiterates Buy on Guardian, Lifts Price Target to $47 on Strengthened Long-Term Growth Conviction
PremiumRatingsAllen Lutz Reiterates Buy on Guardian, Lifts Price Target to $47 on Strengthened Long-Term Growth Conviction
17d ago
Guardian Pharmacy management to meet with Oppenheimer
Premium
The Fly
Guardian Pharmacy management to meet with Oppenheimer
29d ago
Guardian Pharmacy Extends Revolving Credit Facility and Flexibility
Premium
Company Announcements
Guardian Pharmacy Extends Revolving Credit Facility and Flexibility
1M ago
Guardian Pharmacy reports Q1 EPS 29c, consensus 24c
PremiumThe FlyGuardian Pharmacy reports Q1 EPS 29c, consensus 24c
2M ago
Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
Premium
The Fly
Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
2M ago
Guardian Pharmacy initiated with a Buy at BofA
Premium
The Fly
Guardian Pharmacy initiated with a Buy at BofA
2M ago
Guardian Pharmacy 6M share Spot Secondary priced at $31.00
PremiumThe FlyGuardian Pharmacy 6M share Spot Secondary priced at $31.00
4M ago
Guardian Pharmacy 6M share Spot Secondary priced at $31.00
Premium
The Fly
Guardian Pharmacy 6M share Spot Secondary priced at $31.00
4M ago
Guardian Pharmacy prices 6M shares at $31.00 in upsized public offering
Premium
The Fly
Guardian Pharmacy prices 6M shares at $31.00 in upsized public offering
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100